RT Journal Article
SR Electronic
T1 Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e000878
DO 10.1136/jitc-2020-000878
VO 8
IS 1
A1 Ascierto, Paolo Antonio
A1 Fox, Bernard A
A1 Urba, Walter J
A1 Anderson, Ana Carrizosa
A1 Atkins, Michael B
A1 Borden, Ernest C
A1 Brahmer, Julie R
A1 Butterfield, Lisa H
A1 Cesano, Alessandra
A1 Chen, Daniel S
A1 de Gruijl, Tanja D
A1 Dillman, Robert O
A1 Drake, Charles G
A1 Emens, Leisha A
A1 Gajewski, Thomas F
A1 Gulley, James L
A1 Stephen Hodi Jr, F
A1 Hwu, Patrick
A1 Kaufman, David
A1 Kaufman, Howard L
A1 Lotze, Michael T
A1 McNeel, Douglas G
A1 Margolin, Kim A
A1 Marincola, Francesco M
A1 Mastrangelo, Michael J
A1 Maus, Marcela V
A1 Parkinson, David R
A1 Romero, Pedro J
A1 Sondel, Paul M
A1 Spranger, Stefani
A1 Sznol, Mario
A1 Weiner, George J
A1 Wigginton, Jon M
A1 Weber, Jeffrey S
YR 2020
UL http://jitc.bmj.com/content/8/1/e000878.abstract